Company	Share, %
Orchard Therapeutics plc	89.7
Relmada Therapeutics, Inc.	20.66
Bicycle Therapeutics plc	16.38
Nektar Therapeutics	10.02
Pliant Therapeutics, Inc.	9.55
Terns Pharmaceuticals, Inc.	9.44
Jounce Therapeutics, Inc.	8.09
Aligos Therapeutics, Inc.	8.07
AnaptysBio, Inc.	7.61
Pyxis Oncology, Inc.	7.11
Dynavax Technologies Corporation	6.98
Editas Medicine, Inc.	6.69
Editas Medicine	6.69
Silence Therapeutics plc	6.52
Repare Therapeutics Inc.	6.32
Verona Pharma plc	6.15
Ambrx Biopharma Inc.	5.88
4D Molecular Therapeutics, Inc.	5.87
HilleVax, Inc.	5.83
Zura Bio Limited	5.79
SpringWorks Therapeutics, Inc.	5.51
Geron Corporation	5.41
Dyne Therapeutics, Inc.	5.21
IVERIC bio, Inc.	4.72
Autolus Therapeutics plc	4.46
Vigil Neuroscience, Inc.	4.32
Chinook Therapeutics, Inc.	4.18
Guardant Health, Inc.	4.11
Apogee Therapeutics, Inc. Common Stock	3.98
Insmed Incorporated	3.6
Olema Pharmaceuticals, Inc.	3.45
DICE Therapeutics, Inc.	3.35
Syros Pharmaceuticals, Inc.	3.13
ANI Pharmaceuticals	2.86
Astria Therapeutics, Inc.	2.34
Intellia Therapeutics, Inc.	2.34
Reata Pharmaceuticals, Inc.	2.21
Tricida, Inc.	2.12
Axsome Therapeutics, Inc.	2.11
Intra-Cellular Therapies, Inc.	2.07
Alkermes plc	2.07
GH Research PLC	0.96